TUBB3 and blindness (disorder): To obtain further evidence that M109S has a therapeutic effect to prevent blindness caused by optic nerve injury, additional studies will be necessary to determine whether a longer M109S treatment duration (2 weeks and longer) can inhibit the decrease of the numbers of beta-III Tubulin-positive cells.